Karen Kobelski
Virtually all healthcare executives (98%) agree that drug diversion occurs in hospitals, and nearly four in five believe that most drug diversion goes undetected, according to a new survey from Invistics, now part of Wolters Kluwer.
The health-system leaders who were most confident about their own drug diversion programs were those whose systems used machine learning/artificial intelligence (ML/AI) tools to detect diversion. More than half (53%) of the respondents